The French technology group Positive acquired Surfer, the popular content optimization tool. The acquisition helps Positive create a “full-funnel” brand visibility solution together with its marketing ...

Ukrainian President Zelenskyy described his meeting with US President Trump as positive, despite Washington declining to provide Tomahawk missiles. Zelenskyy believes Trump's engagement could help end ...

President Nikos Christodoulides on Thursday said the election of pro-reunification candidate Tufan Erhurman as Turkish Cypriot leader is a “positive development”. “I believe this was a positive ...

The Los Angeles Dodgers have punched their ticket to the World Series after a dominant sweep over the Milwaukee Brewers. With the first game of the Fall Classic set for next Friday, the team from LA ...

Dhanteras, the auspicious start to Diwali, calls for mindful shopping. Experts suggest buying gold, silver, new utensils, and idols of Goddess Lakshmi and Lord Ganesh to invite prosperity. Conversely, ...

Moody's credit rating agency on Friday morning published a special statement praising the deal between Israel and the Hamas terror group and calling it a "positive ...

Neal J. Riley is a digital producer for CBS Boston. He has been with WBZ-TV since 2014. His work has appeared in The Boston Globe and The San Francisco Chronicle. Neal is a graduate of Boston ...

Canada is calling on its $3 trillion pension system to boost domestic investment as it seeks $500 billion in new finance to reboot the economy and lower its dependence on the U.S. Industry minister ...

Financial Performance Despite the positive clinical data, Summit’s financial results reflect the significant investment required for its extensive clinical development program. The company reported: ...

An “aggressive” coyote that attacked a New Jersey man on Tuesday tested positive for rabies after it was euthanized. The man was working in his yard in Saddle River around 6:30 p.m. when the animal ...

Evidence-based recommendations on lorlatinib (Lorviqua) for treating ALK-positive advanced non-small-cell lung cancer that has not been treated with an ALK inhibitor in adults. Lorlatinib is also ...